Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Hematological Inflammatory Parameters Differ When Glycemic Control is Achieved in Patients With Type 2 Diabetes

NCT06228898 is registered in ClinicalTrials.gov with Goztepe Prof Dr Suleyman Yalcın City Hospital as lead sponsor.

NCT NCT06228898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06228898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Hematological Inflammatory Parameters Differ When Glycemic Control is Achieved in Patients With Type 2 Diabetes
Lead sponsor
Goztepe Prof Dr Suleyman Yalcın City Hospital
Phase
Observational
Overall status
Completed
Start date
January 15, 2022
Completion date
January 15, 2023
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poorly controlled diabetes mellitus